Shopping Cart 0
Cart Subtotal
USD 0

India Diagnostic Laboratories Market Outlook to FY’2025- By Government and Private Labs, By Radiology and Pathology, By Organized and Unorganized Players, By Business Model (Standalone, Hospital Based and Diagnostic Chains), By Cities (Tier I, Tier II and Tier III cities) and By Payment Method (Out of Pocket Expenditure, Insurance based and Corporate Spending

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option : Yes
Copy Option : Yes
Deliverable Format : Excel Via Email

Excel Only
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: Excel: Yes/ PDF: No
Deliverable Format : Excel, PDF Via Email

Single and Excel
USD 4000

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 3600

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5000
COVID-19
In-depth Analysis of the COVID-19 impact on India Diagnostic Laboratories Market

Benchmarked the rapid shifts in the strategy of Major Diagnostic Laboratories Players in India and Future Projections for 2025

INQUIRE FOR COVID-19 IMPACT INQUIRE FOR COVID-19 IMPACT

Details

Analyst at Ken Research in their latest publication India Diagnostic Laboratories Market Outlook to FY’2025- By Government and Private Labs, By Radiology and Pathology, By Organized and Unorganized Players, By Business Model (Standalone, Hospital Based and Diagnostic Chains), By Cities (Tier I, Tier II and Tier III cities) and By Payment Method (Out of Pocket Expenditure, Insurance based and Corporate Spending” believe that the market is highly fragmented and there is a dire need for strict regulations. These regulations would help bring about uniformity along with high quality testing standards in the industry. The report further talks about the ecosystem of the diagnostic labs present in India along with a number of segmentations such as radiology and pathology, types of models used, organized and unorganized players and many more. It also provides an investment model for a franchise lab to open up in India. There have been a number of research projects focusing on innovative and less invasive forms of testing. Some of the challenges faced by this industry include price differentiation, lack of knowledge at the consumer end and lack of regulations. Despite the COVID-19 pandemic, this industry sees a bright future. People will be more aware of their health & lifestyle choices and hence, there would definitely be a rise in wellness/preventive testing, helping the diagnostic laboratory market of India to grow further in the coming years.

Industry Overview

The market is highly fragmented with only four major PAN-India level players. It is still at its’ growing stage. However, the unorganized sector dominates the market’s revenue currently. The highest penetration of the labs is in Tier I cities, which is also the place for their reference labs. Digitalisation in the chain of diagnostics has helped remove mistakes from the time the samples have been collected to the last process of delivering the report to the customer. The major drivers for this market include the high elderly population and the shift from non-communicable to communicable diseases in India. Radiology test market has evolved over time with the advancement in the existing technology of imaging machines such as PET-scan which added more clarity in the diagnosis of the patient’s disease. Whereas for pathology, the segment has gained dominance in the market owing to the fact that it is the preferred line of diagnosis for the majority of diseases prevalent in India including infectious diseases.

Industry Segmentation

The report explores segments such as government and private diagnostic labs within the country. It is the private diagnostic labs market which is further broken down into various segments. The market is dominated by unorganized players. Medical insurance in the country is currently focused upon the clinical side and not so much towards the diagnostic sector. As of now, majority of the payment is done through out of pocket expenditure. There are a number of standalone centers in the market which hold the highest share. The diagnostic chains are further split into regional and PAN-India level labs. Within the Indian market, there are a number of doctors who have tie ups with labs and hence the customers coming from a referral hold a prominent share in the overall market. The revenue earned by a lab from a referral customer is split between the doctor and the lab. In the future, it is expected that testing for wellbeing would increase as people are now making a conscious effort to stay fit, however testing for sick care would still dominate the market. 

Bottlenecks Faced in the Industry

Due to lack of regulations, there are hardly any barriers to entry. As a result there are a number of labs which have opened throughout the country. Majority of them fail to follow protocols and lack accreditations. There is also a lack of price standardization due to which there is a high level of discrepancies between diagnostic test prices of Tier I and Tier III cities. The penetration of labs in the rural parts of India is also low. When compared to a developed market like that of UK wherein 80% of the medical expense is incurred by the government, India falls behind in both aspects and is inclined towards out of pocket expenditure.

Competition Scenario in the Industry

The market structure is highly fragmented with unorganized players dominating the industry and has presence majorly in Tier-2 and Tier-3 cities. In the past few years, there have been a number of acquisitions and mergers with larger players acquiring smaller players helping the organized sector grow. It also facilitates a larger reach and more comprehensive test menus. There are majorly four PAN-India players which are well established in the market, they include Dr. Lal Pathlabs, Thyrocare Technologies, Metropolis Healthcare and SRL Diagnostics. These labs give utmost focus on research and development in order to introduce new and less invasive tests.

Future Strategies-The Way Forward

Government regulations are in focus which would help in streamlining the market in the coming years. As more companies enter the organized sector, there would be an increasing emphasis on the hub and spoke model in order to bring in volumes required for a commercial entity to survive in the market. Growth of 3D printing, which allows radiologists and clinicians to bring to life body parts and tumors which were previously available only as flat diagrams, will help revolutionize the market. India is set to increase its public health spending to 2.5% of its GDP by 2025 which would help cut down on out of pocket expenditure on healthcare services. This would be a major boost to the diagnostic sector of the industry. Consumer satisfaction would be a focus point in order to retain brand equity. Home sample collections are expected to further increase thereby bringing in convenience to the patient and facilitating further penetration of organized players in the market.

Key Segments Covered

India Diagnostic Laboratories Market

  • Revenue Segmentation by Government and Private Labs

Government Labs

Private Labs

India Private Diagnostic Laboratories Market

  • Revenue Segmentation by Pathology and Radiology

Pathology Sector

Radiology Sector

  • Revenue Segmentation by Pathology

Clinical Biology

Hematology

Surgical Pathology

Histopathology

Clinical Microbiology

Molecular Biology

Others

  • Revenue Segmentation by Radiology

X-rays

Sonography

MRI

CT Scans

Mammography

PET

Others

  • Revenue Segmentation by Business Model

Standalone

Diagnostic Chains

Hospital Based Labs

  • Revenue Segmentation by Diagnostic Chains 

Regional Chains

Large PAN-India Chains

  • Revenue Segmentation by Tier I, II and III Cities 

Tier I cities

Tier II cities

Tier III cities

  • Revenue Segmentation by Organized and Unorganized Players 
  • Revenue Segmentation by Type of Customers

Referrals

Walk Ins

Corporate Client

  • Revenue Segmentation by Payment Method

Out of Pocket Expenditure

Corporate Spending

Insurance

Key Target Audience

Government Diagnostic Labs

Private Diagnostic Labs

Research Labs

Medical Insurance Companies

Medical Device Manufacturers

Industry Associations

Government Bodies

Investors/VC’s

Time Period Captured in the Report:

Historical Period: FY’2015-FY’2020

Forecast Period: FY’2020-FY’2025

Companies Mentioned:

Dr. Lal Pathlabs

SRL Diagnostics

Metropolis Healthcare

Thyrocare Technologies

Medall Healthcare Pvt Ltd

Suraksha Diagnostics Pvt Ltd

Suburban Diagnostics

Neuberg Diagnostics

Key Topics Covered in the Report

Spread of Communicable and Non-Communicable Diseases in India

Market Sizing Analysis of Diagnostic Labs in India

Ecosystem of Diagnostic Labs in India

Operating Models in India Diagnostic Labs

Pricing Analysis in India Diagnostic Labs Market

Value Chain Analysis of India Diagnostic Labs Market

Decision Making Parameters for a Diagnostic Lab

Issues and Challenges in the Industry

Government Regulations in the Industry

Segmentation by Radiology and Pathology

Segmentation by Type of Business Model (Standalone, Hospital Based Labs and Diagnostic Chains)

Upcoming Trends and Technologies in the Market

Competition Scenario and Market Share

Investment Model for a Franchise Lab in India

Success Stories of Diagnostic Labs in India 

READ MORE

Table Of Content

Scope

1.            Executive Summary

2.            Research Methodology

2.1.        Market Definitions

2.2.        Abbreviations

2.3.        Market Size and Modeling

3.            Communicable and Non Communicable Diseases in India

4.            India Diagnostic Laboratory Market Ecosystem

5.            Operating Models Followed  in India Diagnostic Laboratories Market

5.1.        Hub-and-Spoke Model

5.2.        Customer Reach Out Model for Diagnostic Chains

6.            India Diagnostic Laboratories Market Pricing Analysis

6.1.        Government Initiative to Reduce Out of Pocket Expenditure

7.            India Diagnostic Laboratories Market Value Chain, FY’ 2020

8.            India Diagnostic Laboratories Market Size, FY’2015-FY’2020

8.1.        By Government and Privately Owned Diagnostic Laboratories, FY’2020

9.            India Private Diagnostic Laboratories Market Segmentation FY’2020

9.1.        By Radiology and Pathology Laboratories, FY’2020

9.2.        By Business Model (Standalone Centers/Polyclinics, Hospital Based Labs and Diagnostic Chains), FY’2020

9.3.        By Diagnostic Chains (Regional Chains and Large PAN-India Labs) FY’2020

9.4.        By Tier I, Tier II, and Tier III Cities, FY’2020

9.5.        By Organized and Unorganized Players, FY’2020

9.6.        By Type of Customers (Referrals, Walk Ins and Corporate Clients), FY’2020

9.7.        By Cause for Testing (Sick Care and Wellness), FY’2020

9.8.        By Payment Method (Out of Pocket Expenditure, Corporate Spending and Insurance), FY’20

10.         Snapshot on India Private Pathology Tests Market

10.1.     India Private Pathology Tests Market Size By Revenue, FY’2020

10.2.     India Pathology Tests Market Segmentation By Type of Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology and Molecular Biology), FY’2020

11.         Snapshot on India Private Radiology Tests Market

11.1.     India Private Radiology Tests Market Size By Revenue, FY’2020

11.2.     India Private Radiology Tests Market Segmentation By Type of Tests (X-Rays, Sonography, MRI, CT Scans, Mammography and PET), FY’2020

12.         Decision Making Process of Customers for Choosing Diagnostic Laboratories

13.         Trends and Developments in India Private Diagnostic Laboratories Market

13.1.     Advancements in Technology

13.2.     Collaboration of Diagnostic Healthcare Service Providers with Corporate Entities

13.3.     Increasing Penetration of Medical Insurance

13.4.     Regulating Telemedicine Industry Helping Diagnosis

13.5.     Shift Towards Molecular Pathology and Genetics Testing

14.         Growth Drivers for the Diagnostic Laboratory Industry

14.1.     Growth of Population and Income Levels in India

14.2.     Rise of Communicable and Non-Communicable Diseases

14.3.     Usage of Laboratory Diagnostics as a tool in Clinical Practice

14.4.     India Emerging as a Medical Tourism Destination

15.         Issues and Challenges in the Indian Diagnostics Industry

15.1.     Lack of Regulations

15.2.     High Equipment Cost

15.3.     Lack of Knowledge Among the Consumers

15.4.     Growing Operating Expenses

16.         Industry Speaks

16.1.     Interview with Mr. Arindam Haldar, Chief Executive Officer at SRL Limited

16.2.     Interview with Dr. Kunal Sharma, SRL Reference laboratory and Consultant Oncopathologist- Fortis Hospitals, Bangalore

16.3.     Interview with Mr. Indranil Roy Choudhury, Chief Operating Officer at Diagno Labs Pvt Ltd

17.         Investment Model for Setting Up a Diagnostic Laboratory

18.         Regulatory Environment for India Diagnostic Laboratories Market

18.1.     Licenses and Other Regulations

19.         India Diagnostic Laboratory Market SWOT Analysis

20.         India Diagnostic Laboratories Market Company Profiles (Company Overview, USP, Services Portfolio, Number of Locations, Number of Centers, Business Strategies, Number of Employees, Mergers and Acquisitions and Company Financials)

20.1.     SRL Diagnostics, FY’2020

20.2.     Dr. Lal Pathlabs, FY’2020

20.3.     Metropolis Healthcare Limited, FY’2020

20.4.     Thyrocare Technologies Limited , FY’2020

20.5.     Suraksha Diagnostics Pvt Ltd, FY’2020

20.6.     Medall Healthcare Pvt. Ltd., FY’2020

20.7.     Suburban Diagnostics, FY’2020

20.8.     Neuberg Diagnostics, FY’2020

21.         India Diagnostic Laboratories Market Competitive Landscape

21.1.     India Diagnostic Laboratories Market Cross Comparison for Major Players (Dr. Lal Pathlab, SRL Diagnostics, Metropolis Healthcare and Thyrocare Technologies Ltd ) Based on Accreditations, International Presence, Revenue in INR Cr (FY’2019) and Number of Lbs, FY’2020

21.2.     India Diagnostic Laboratory Market Strengths and Weakness of Major Players (Dr. Lal Pathlabs, SRL Diagnostics, Metropolis Healthcare and Thyrocare Techbologies Limited), FY’20

21.3.     Market Share of Major Players in India Private Organised  Diagnostic Laboratories Market (Dr. Lal Pathlabs, SRL Diagnostics, Thyrocare Technologies, Metropolis Healthcare, Medall Healthcare Pvt Ltd., Suraksha Diagnostics Pvt Ltd, Suburban Diagnostics and Others), FY’2019

22.         India Diagnostic Laboratories Market Future Outlook and Projections, FY’2020 – FY’2025

22.1.     Revenue by Government and Private Diagnostic Laboratories, FY’2020 and FY’2025

22.2.     Impact of COVID-19 on the Indian Diagnostic Laboratories Market

23.         India Private Diagnostic Laboratories Market Future Outlook, FY’2020 and FY’2025

23.1.     Revenue By Radiology and Pathology Tests, Fy’2020 and FY2025

23.1.     Revenue By Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology Molecular Biology and Others), Fy’2020 and FY2025

23.2.     Revenue By Radiology Tests (X-Rays, Sonography, MRI, CT Scans, Mammography, PET and Others ), Fy’2020 and FY2025

23.3.     Revenue By Tier I, Tier II and Tier III Cities, FY’2020 and FY’2025

23.4.     Revenue By Organized and Unorganized Players, FY’2020 and FY’2025

23.5.     Revenue By Business Model (Standalone Centers/Polyclinics, Hospital Based Labs and Diagnostic Chains), FY’2020 and FY’2025

23.1.     Revenue by Diagnostic Chains (Regional Labs and Large PAN-India Labs), FY’2020 and FY’2025

23.2.     Revenue by Type of Customers (Referrals, Walk Ins and Corporate Clients) FY’2020 and FY’2025

23.3.     Revenue By Cause for Testing (Wellness and Sick-Care) FY’2020 and FY’2025

Revenue by Payment Method ( Out of Pocket Expenditure, Insurance and Corporate Spending ) FY’2020 and FY’2025

24.         India Diagnostic Laboratories Market Success Stories

24.1.     Krsnaa Diagnostics – Sustainable PPPs

24.2.     Healthians- Asset Light Model

25.         Analyst Recommendations

Disclaimer

Contact Us


List Of Figure

Figure 1‑1: India Diagnostic Laboratories Market Flowchart on the basis of Revenue in INR Cr, FY’2020

Figure 1‑2: India Diagnostic Laboratories Market Flowchart in terms of Revenue (INR Cr), FY’25

Figure 3‑1: Mortality reported by Major Communicable Diseases in India in 2018

Figure 5‑1: India Diagnostic Laboratories Market Hub-and-Spoke Model Followed by Diagnostic Chains

Figure 5‑2: India Diagnostics Laboratory Market Hub and Spoke Model used in a Regional Lab

Figure 5‑3: India Diagnostics Laboratory Market Logistics Functioning in Customer Reach Out Model

Figure 8‑1: India Diagnostic Laboratories Market on the basis of Revenue in INR Crore and Growth Rate in Percentage (%), FY’2015 - FY’2020

Figure 8‑2: India Diagnostic Laboratories Market by Government and Privately owned Laboratories on the basis of Revenue in Percentage, FY’2020

Figure 9‑1: India Private Diagnostic Laboratories Market Segmentation by Pathology Labs and Radiology Labs on the basis of Revenue in Percentage (%), FY’2020

Figure 9‑2: India Private Diagnostic Laboratories Market Segmentation by Standalone Centers/Polyclinics, Hospital Based Labs and Diagnostic Chains on the basis of Revenue in Percentage, FY’2020

Figure 9‑3: India Private Diagnostic Laboratories Market Segmentation by Diagnostic Chains (Regional Labs and PAN-India Level Labs) on the basis of Revenue in Percentage, FY’2020

Figure 9‑4: India Private Diagnostic Laboratories Market Segmentation by Tier Cities (Tier I, Tier II, Tier III) on the basis of Revenue in Percentage, FY’2020

9‑5: India Private Diagnostic Laboratories Market Segmentation by Organised and Unorganized Players on the Basis of Revenue in Percentage (%), FY’2020

Figure 9‑6: India Private Diagnostic Laboratories Market Segmentation by Type of Customers (Referrals, Walk Ins and Corporate Clients) on the basis of Revenue in Percentage (%), FY’2020

Figure 9‑7: India Private Diagnostic Laboratories Market Segmentation by Cause for Testing (Sick Care and Wellness) on the basis of Revenue in Percentage (%), FY’2020

Figure 9‑8: India Private Diagnostic Laboratories Market Segmentation by Payment Method (Out of Pocket Expenditure, Corporate Spending and Insurance) on the basis of Revenue in Percentage (%), FY’2020

Figure 10‑1: India Private Pathology Tests Market Segmentation by Type of Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology, Molecular Biology and others) on the Basis of Revenue in Percentage, FY’2020

Figure 11‑1: India Private Radiology Tests Market Segmentation by Type of Tests (X-Ray, Sonography, MRI, CT Scan, Mammography, PET/SPECT) on the basis of Revenue in Percentage, FY’2020

Figure 13‑1: Medical Insurance Market in India on the Basis of Premium in INR Crore, FY’2015 - FY’2019

Figure 14‑1: Population Growth in India in Crore, 2013-2020 (P)

Figure 20‑1: Dr. Lal Pathlabs Financial Performance including Revenue from Operations in India in INR Cr, FY’2015-FY-2019

Figure 20‑2: Dr. Lal Pathlabs Geographical Revenue Breakup in terms of Percentage (%), FY’2018 and FY’2019

Figure 20‑3: Dr. Lal Pathlabs Number of Clinical Labs in India, FY’2015-FY’2019

Figure 20‑4: Thyrocare Technologies Limited Geographical Revenue Breakup in terms of Percentage (%), FY’2018 and FY’2019

Figure 20‑5: Operational Performance of Thyrocare Technologies Limited on the basis of Samples Processed (‘000), FY’2015-FY’2019

Figure 21‑1: India Private Organised Diagnostic Laboratories Market Competition including Market Share for Major Companies (Dr. Lal Pathlabs, SRL Diagnostics, Thyrocare Technologies, Metropolis Healthcare, Medall Healthcare Pvt Ltd., Suraksha Diagnostics Pvt Ltd, Suburban Diagnostics and others) in Revenue Percentage (%), FY’2019

Figure 22‑1: India Diagnostic Laboratories Market Future Outlook on the basis of Revenue in INR Crore and Growth Rate in Percentage (%), FY’2020-FY’2025

Figure 22‑2: India Diagnostic Laboratories Market Segmentation Future Outlook by Government and Private Laboratories on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑1: India Private Diagnostic Laboratories Market Segmentation Future Outlook  by Pathology and Radiology Tests on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑2: India Private Diagnostic Laboratories Market Segmentation Future Outlook  by Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology, Molecular Biology and others) on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑3: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Radiology Tests (X-Rays, Sonography, MRI, CT Scans, Mammography, PET and others) on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑4: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Tier I, Tier II and Tier III Cities on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑5: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Organized and Unorganized Players on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑6: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Model Type (Standalone centers, Hospital Based Labs and Diagnostic Chains) on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑7: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Diagnostic Chains (Regional Labs and Large PAN-India Labs) on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑8: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Type of Customers (Referrals, Walk Ins and Corporate Clients) on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑9: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Cause of Testing (Wellness and Sick Care) on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑10: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Payment Method (Out of Pocket Expenditure, Insurance and Corporate Spending) on the Basis of Revenue in Percentage, FY’2020 and FY’2025


List Of Table

Table 2‑1: Consolidated Research Approach for India Diagnostic Labs Market

Table 2‑2: Sample Size Including Major Players in India Diagnostic Labs Market and Industry Experts

Table 2‑3: Sample Size Inclusion Table Including Respondent Category and Percentage of Sample Size

Table 2‑4: Tentative Set of Questions Asked by Mode of Entities and Desired Outcome

Table 2‑5: Correlation Matrix of India Diagnostic Labs Market

Table 2‑6: Regression Coefficients Outputs of India Diagnostic Labs Market

Table 3‑1: Demographic Factors including Birth Rate, Death Rate and Natural Growth Rate for India on the basis of Urban and Rural Regions in Percentage (%), 2012-2017

Table 3‑2: Deaths caused by Acute Respiratory Infections, Acute Diarrhea and Pneumonia in India State Wise, 2017 and 2018(P)

Table 3‑3: Number of People Diagnosed with Non Communicable Diseases (Diabeters, Hypertension, HTN &DM, Cardiovascular Diseases (CVDs), Stroke and Common Cancer) in 2018

Table 4‑1: India Diagnostic Laboratory Market Ecosystem , FY’2020

Table 5‑1: India Diagnostics Laboratory Market on the basis of Different Type of Business Models (Hospital based labs, Diagnostic Chains and Standalone Centers)

Table 5‑2: India Diagnostics Laboratory Market Components of Hub-and-Spoke Model

Table 6‑1: India Diagnostic Laboratory Market Price/Average Cost of Diagnostic Tests across Cities, 2017

Table 7‑1: India Diagnostic Laboratories Market Value Chain, FY’2020

Table 7‑2: Role of Entities in the India Diagnostic Laboratory Market Value Chain

Table 8‑1: India Diagnostic Laboratory Market Cross Comparison of Privately Owned Laboratories and Government Owned Laboratories on the basis of Convenient Sample Collection, Customer Reach, Time taken for Results and Examples, FY’20

Table 8‑2: India Diagnostic Laboratory Market Comparative Prices for Key Diagnostic Tests in Government Owned and Privately Owned Laboratories, 2019

Table 8‑3: India Diagnostic Laboratories Market by Government and Privately owned Laboratories on the basis of Revenue in INR Crore, FY’2020

Table 9‑1: Cross Comparison of Pathology and Radiology Laboratories on the basis of Growth Factors, Economies of Scale, Barriers to Entry and Specific Accreditations/Approvals Required

Table 9‑2: India Private Diagnostic Laboratories Market Segmentation by Pathology Tests and Radiology Tests on the basis of Revenue in terms of INR Crore, FY’2020

Table 9‑3: India Diagnostic Laboratory Market Cross Comparison of Standalone/Polyclincs, Hospital Based Labs and Diagnostics Chains on the basis of Type of Players, Availability of Tests, Investments and Examples, FY’ 2020

Table 9‑4: India Private Diagnostic Laboratories Market Segmentation by Model Type (Standalone Centers/Polyclinics, Hospital Based Labs and Diagnostic Chains) on the Basis of Revenue in INR Crore, FY’2020

9‑5: India Diagnostic Laboratory Market Cross Comparison of Diagnostic Chains (Regional Chains and Large PAN-India Labs on the basis of Number of Players, Customer Base and Examples), FY’20

Table 9‑6: India Private Diagnostic Laboratories Market Segmentation by Diagnostic Chains (Regional Labs and PAN-India Level Labs) on the Basis of Revenue in INR Crore, FY’2020

Table 9‑7: India Private Diagnostics Laboratory Market Cross Comparison of Tier I, Tier II and Tier III cities on the basis of Composition of Establishments, Pricing and Growth Factors, FY’2020

Table 9‑8: India Private Diagnostic Laboratories Market Segmentation by Tier Cities (Tier I, Tier II, Tier III) on the basis of Revenue in INR Crore, FY’2020

Table 9‑9: India Private Diagnostics Laboratory Market Cross Comparison of Organised Players and Unorganized Players on the basis of Presence, Operating Model, Promotional Activities and Regulations Followed, FY’2020

Table 9‑10: Major Organized Players in India Private Laboratories Market and their Presence across India, 2019

Table 9‑11: India Private Diagnostic Laboratories Market Segmentation by Organised and Unorganized Players on the basis of Revenue in INR Crore, FY’2020

Table 9‑12: India Private Diagnostic Laboratory Market Cross Comparison of Type of Customers (Referrals, Walk Ins, Corporate Clients) on the basis of Type of Model Preferred, Type of Testing Conducted and Mode of Payment, FY’2020

Table 9‑13: India Private Diagnostic Laboratories Market Segmentation by Type of Customers (Referrals, Walk-Ins and Corporate Clients on the basis of Revenue in INR Crore, FY’2020

Table 9‑14: India Private Diagnostic Laboratories Market Segmentation by Cause for Testing (Sick Care and Wellness) on the basis of Revenue in INR Crore, FY’2020

Table 9‑15: India Private Diagnostic Laboratories Market Segmentation by Payment Method (Out of Pocket Expenditure, Corporate Spending and Insurance) on the basis of Revenue in INR Crore, FY’2020

Table 10‑1: India Private Pathology Tests Market Cross Comparison of Type of Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology and Molecular Biology) on the basis of Purpose, Common Tests Performed in India and Growth Factors,  FY’2020

Table 10‑2: Private Pathology Tests Market Segmentation by Type of Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology, Molecular Biology and others) on the Basis of Revenue in INR Crore, FY’2020

Table 11‑1: India Private Radiology Tests (X-rays, Sonography, MRI, CT Scans, Mammography and PET) Cross Comparison on the basis of Purpose, Average Price and Growth Factor, FY’2020

Table 11‑2: India Private Radiology Tests Market Segmentation by Type of Tests (X-Ray, Sonography, MRI, CT Scan, Mammography, PET/SPECT) on the basis of Revenue in INR Crore, FY’2020

Table 12‑1: India Diagnostic Laboratory Market Rationale for Decision Making Process of Customers while Choosing a Diagnostic Laboratory, FY’2020

Table 17‑1: Parameters for Setting up a Franchise Laboratory in India

Table 17‑2: Equipment Expenditure for Pathology Laboratories in India in INR

Table 17‑3: Equipment Expenditure for Radiology Laboratories in India in INR

Table 17‑4: Total Fixed Cost for Setting up a Franchise Diagnostic Laboratory in India in INR

Table 17‑5: Annual Salaries of Diagnostic Laboratories Professionals on the basis of Salaries per Profession in terms of INR in India

Table 17‑6: Annual Human Resource Expenses in terms of INR in India

Table 17‑7: Annual Expenses of Franchised Diagnostic Laboratory in India in INR

Table 17‑8: Means of Finance for Setting up a Franchised Diagnostic laboratory in India in INR

Table 17‑9: Annual Operating Expenses of a Franchised Diagnostic laboratory in India in INR

Table 17‑10: Financial Indicators Related to Franchised Diagnostic laboratory in India in INR

Table 19‑1: India Diagnostic Laboratory Market SWOT Analysis

Table 20‑1: Company Profile of SRL Diagnostics including Company Overview, USP, Services Portfolio , Number of Locations, Number of Centers, Service Portfolio, Business Strategies, Awards, Joint Ventures, Mergers and Acquisitions and Recent Developments, FY’2020

Table 20‑2: SRL Diagnostics Financial Parameters including Revenue from Operations, Other Incomes, Total Income, Profit before Tax and Profit for the Year in INR CR, FY’2016-FY’2019

Table 20‑3: Company Profile of Dr. Lal Pathlabs including Company Overview, USP, Number of Locations, Number of Tests, Service Portfolio, Business Strategies, Recent Developments, Mergers and Acquisitions and Number of Employees, FY’2020

Table 20‑4: Dr. Lal Pathlabs Financial Parameters including Revenue from Operations, Other Income, Total Income, Profit before Tax, Profit After Tax and EBITA Margin (%), in INR Cr, FY’2015-FY’2019

Table 20‑5: Company Profile of Metropolis Healthcare including Company Overview, US, Number of Centers, Service Portfolio, Business Strategies, Number of Employees, Awards, Recent Developments and Mergers and Acquisitions, FY’2020

Table 20‑6: Metropolis Healthcare Limited Number of Clinics State Wise in India, FY’ 2019

Table 20‑7: Metropolis Healthcare Limited Number of Tests (Mn) and Revenue per Test (INR), FY2016-FY’2019

Table 20‑8: Metropolis Healthcare Limited Financial Parameters including Revenue from Operations, Other Revenue, Total Revenue, Profit before Tax and EBITDA (%) in INR Crore, FY’2018 and FY’2019

Table 20‑9: Metropolis Healthcare Limited Financial Parameters including Revenue Breakup by Geography (India and Overseas) in INR Crore, FY’2018 and FY’2019

Table 20‑10: Company Profile of Thyrocare Technologies Limited including Company Overview, USP, Number of Locations, Number of Tests, Services Portfolio, Number of Centers, Business Strategies, Number of Employees and Recent Developments, FY’2020

Table 20‑11: Thyrocare Technologies Finanacial Parameters including Income from Operations, EBITDA, Profit before tax and Profit for the Year in INR Crore, FY’2015-FY’2019

Table 20‑12: Company Profile of Suraksha Diagnostics Pvt. Ltd. including Company Overview, USP , Service Portfolio, Number of Diagnostic Centers, Location, Recent Developments and Awards, FY’2020

Table 20‑13: Suraksha Diagnostics Pvt Ltd. Financial Parameters including Revenue form Operations, Other Income, Total Revenue and Total Profit/Loss for the year in INR Cr, FY’2014 – FY’2019

Table 20‑14: Company Profile for Medall Healthcare Pvt. Ltd. including Company Overview, Number of Diagnostic Centers, Number of Tests Conducted, Location, Number of Employees, Service Portfolio, Recent Developments and Awards, FY’2020

Table 20‑15: Medall Healthcare Financial Parameters including Total Income and Profit/Loss for the Year in INR Cr, FY’2014 – FY’2018

Table 20‑16: Company Profile of Suburban Diagnostics Pvt. Ltd. including Company Overview, USP , Service Portfolio, Number of Diagnostic Centers, Location, Recent Developments and Awards, FY’2019

Table 20‑17: Suburban Diagnostics Pvt Ltd. Financial Parameters including Revenue from Operations, Other Income, Total Revenue and Total Profit/Loss for the year in INR Cr, FY’2014 – FY’2019

Table 20‑18: Company Profile of Neuberg Diagnostics  including Company Overview, USP , Service Portfolio, Number of Diagnostic Centers, Location, Recent Developments. Accreditations, Awards, New Technologies and Investments, FY’2020

Table 21‑1: India Diagnostic Market Cross Comparison of Major Players including Dr. Lal Pathlab, SRL Diagnostics, Metropolis Healthcare and Thyrocare Technologies Ltd based on Accreditations, International Presence, Revenue in INR Cr (FY’2019) and Number of Labs, FY’2020

Table 21‑2: India Diagnostic Laboratory Market Strengths and Weakness of Major Players including Dr. Lal Pathlabs, SRL Diagnostics, Metropolis Healthcare and Thyrocare Techbologies Limited, FY’20

Table 21‑3: India Diagnostic Laboratory Market Price Comparison for Different Pathology Tests (Lipid Profile, Vitamin B12 and Vitamin D) in Dr. Lal Pathlabs, SRL Diagnostics, Metropolis Healthcare and Thyrocare Technologies Limited, in Mumbai FY’2019

Table 21‑4: India Private Organised Diagnostic Laboratories Market Competition including Market Share for Major Companies (Dr. Lal Pathlabs, SRL Diagnostics, Thyrocare Technologies, Metropolis Healthcare, Medall Healthcare Pvt Ltd., Suraksha Diagnostics Pvt Ltd, Suburban Diagnostics and others)  in Revenue (INR Cr), FY’2019

Table 22‑1: India Diagnostic Laboratories Market Segmentation Future Outlook by Government and Private Laboratories Tests on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 22‑2: NABL Accredited Private Labs for COVID-19 Testing Statewise, March 2020

Table 23‑1: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Pathology and Radiology Tests on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑2: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology, Molecular Biology and others ) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑3: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Radiology Tests (X-Rays, Sonography, MRI, CT Scans, Mammography PET and others) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑4: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Tier I, Tier II and Tier III Cities on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑5: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Organised and Unorganized Players on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑6: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Model Type (Standalone centers, Hospital Based Labs and Diagnostic Chains) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑7: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Diagnostic Chains (Regional Labs and Large PAN-India Labs) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑8: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Type of Customers (Referrals, Walk Ins and Corporate Clients) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑9: India Private Diagnostic Laboratories Market Segmentation Future Outlook by by Cause of Testing (Wellness and Sick Care) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑10: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Payment Method (Out of Pocket Expenditure, Insurance and Corporate Spending) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 24‑1: India Diagnostic Laboratories Market Cross Comparison of Prices at KRsnaa Diagnostics, Apollo, SRL Diagnostics, Vijaya Diagnostics and Medall, FY’19

Table 25‑1: Analyst Recommendations for India Private Diagnostic Laboratories Market

Licence Rights

License Type Excel Only Single User Single User + Excel Hard Copy Corporate User License
User Sharing Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Access to Printed Report; No Soft Copy Multiple Users within the Company/ Enterprise
Print Option
Copy Option :Yes :No
Citation Yes (Not Publically; but to Private Parties within the company/ affiliate)
Deliverable Format :via Email :via Email ; :via Email Printed Publication/ Book by Post ; :via Email
Customization 20%
Analyst Time (Post Purchase Queries on Call/ Email)
Disclaimer : In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Covid 19 Inquiry

In-depth Analysis of the COVID-19 impact on India Diagnostic Laboratories Market

Respecting industry experts that are helping companies to survive and to sustain in this economic pandemic. We are working day and night to aid companies in taking rapid-decisions by finding

 

  • COVID-19 Impact on diagnostic services market, growth/decline in the industry player’s revenue, new service offerings, government support and regulations  etc.

  • How major diagnostic laboratories services players are making rapid shifts in their strategies to survive the affects of the pandemic

  • Major short-term and long term shifts in the industry performance

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Key Segments Covered

India Diagnostic Laboratories Market

  • Revenue Segmentation by Government and Private Labs

Government Labs

Private Labs

India Private Diagnostic Laboratories Market

  • Revenue Segmentation by Pathology and Radiology

Pathology Sector

Radiology Sector

  • Revenue Segmentation by Pathology

Clinical Biology

Hematology

Surgical Pathology

Histopathology

Clinical Microbiology

Molecular Biology

Others

  • Revenue Segmentation by Radiology

X-rays

Sonography

MRI

CT Scans

Mammography

PET

Others

  • Revenue Segmentation by Business Model

Standalone

Diagnostic Chains

Hospital Based Labs

  • Revenue Segmentation by Diagnostic Chains 

Regional Chains

Large PAN-India Chains

  • Revenue Segmentation by Tier I, II and III Cities 

Tier I cities

Tier II cities

Tier III cities

  • Revenue Segmentation by Organized and Unorganized Players 
  • Revenue Segmentation by Type of Customers

Referrals

Walk Ins

Corporate Client

  • Revenue Segmentation by Payment Method

Out of Pocket Expenditure

Corporate Spending

Insurance

Key Target Audience

Government Diagnostic Labs

Private Diagnostic Labs

Research Labs

Medical Insurance Companies

Medical Device Manufacturers

Industry Associations

Government Bodies

Investors/VC’s

Time Period Captured in the Report:

Historical Period: FY’2015-FY’2020

Forecast Period: FY’2020-FY’2025


Companies

Companies Mentioned:

Dr. Lal Pathlabs

SRL Diagnostics

Metropolis Healthcare

Thyrocare Technologies

Medall Healthcare Pvt Ltd

Suraksha Diagnostics Pvt Ltd

Suburban Diagnostics

Neuberg Diagnostics

Analyst at Ken Research in their latest publication India Diagnostic Laboratories Market Outlook to FY’2025- By Government and Private Labs, By Radiology and Pathology, By Organized and Unorganized Players, By Business Model (Standalone, Hospital Based and Diagnostic Chains), By Cities (Tier I, Tier II and Tier III cities) and By Payment Method (Out of Pocket Expenditure, Insurance based and Corporate Spending” believe that the market is highly fragmented and there is a dire need for strict regulations. These regulations would help bring about uniformity along with high quality testing standards in the industry. The report further talks about the ecosystem of the diagnostic labs present in India along with a number of segmentations such as radiology and pathology, types of models used, organized and unorganized players and many more. It also provides an investment model for a franchise lab to open up in India. There have been a number of research projects focusing on innovative and less invasive forms of testing. Some of the challenges faced by this industry include price differentiation, lack of knowledge at the consumer end and lack of regulations. Despite the COVID-19 pandemic, this industry sees a bright future. People will be more aware of their health & lifestyle choices and hence, there would definitely be a rise in wellness/preventive testing, helping the diagnostic laboratory market of India to grow further in the coming years.

Industry Overview

The market is highly fragmented with only four major PAN-India level players. It is still at its’ growing stage. However, the unorganized sector dominates the market’s revenue currently. The highest penetration of the labs is in Tier I cities, which is also the place for their reference labs. Digitalisation in the chain of diagnostics has helped remove mistakes from the time the samples have been collected to the last process of delivering the report to the customer. The major drivers for this market include the high elderly population and the shift from non-communicable to communicable diseases in India. Radiology test market has evolved over time with the advancement in the existing technology of imaging machines such as PET-scan which added more clarity in the diagnosis of the patient’s disease. Whereas for pathology, the segment has gained dominance in the market owing to the fact that it is the preferred line of diagnosis for the majority of diseases prevalent in India including infectious diseases.

Industry Segmentation

The report explores segments such as government and private diagnostic labs within the country. It is the private diagnostic labs market which is further broken down into various segments. The market is dominated by unorganized players. Medical insurance in the country is currently focused upon the clinical side and not so much towards the diagnostic sector. As of now, majority of the payment is done through out of pocket expenditure. There are a number of standalone centers in the market which hold the highest share. The diagnostic chains are further split into regional and PAN-India level labs. Within the Indian market, there are a number of doctors who have tie ups with labs and hence the customers coming from a referral hold a prominent share in the overall market. The revenue earned by a lab from a referral customer is split between the doctor and the lab. In the future, it is expected that testing for wellbeing would increase as people are now making a conscious effort to stay fit, however testing for sick care would still dominate the market. 

Bottlenecks Faced in the Industry

Due to lack of regulations, there are hardly any barriers to entry. As a result there are a number of labs which have opened throughout the country. Majority of them fail to follow protocols and lack accreditations. There is also a lack of price standardization due to which there is a high level of discrepancies between diagnostic test prices of Tier I and Tier III cities. The penetration of labs in the rural parts of India is also low. When compared to a developed market like that of UK wherein 80% of the medical expense is incurred by the government, India falls behind in both aspects and is inclined towards out of pocket expenditure.

Competition Scenario in the Industry

The market structure is highly fragmented with unorganized players dominating the industry and has presence majorly in Tier-2 and Tier-3 cities. In the past few years, there have been a number of acquisitions and mergers with larger players acquiring smaller players helping the organized sector grow. It also facilitates a larger reach and more comprehensive test menus. There are majorly four PAN-India players which are well established in the market, they include Dr. Lal Pathlabs, Thyrocare Technologies, Metropolis Healthcare and SRL Diagnostics. These labs give utmost focus on research and development in order to introduce new and less invasive tests.

Future Strategies-The Way Forward

Government regulations are in focus which would help in streamlining the market in the coming years. As more companies enter the organized sector, there would be an increasing emphasis on the hub and spoke model in order to bring in volumes required for a commercial entity to survive in the market. Growth of 3D printing, which allows radiologists and clinicians to bring to life body parts and tumors which were previously available only as flat diagrams, will help revolutionize the market. India is set to increase its public health spending to 2.5% of its GDP by 2025 which would help cut down on out of pocket expenditure on healthcare services. This would be a major boost to the diagnostic sector of the industry. Consumer satisfaction would be a focus point in order to retain brand equity. Home sample collections are expected to further increase thereby bringing in convenience to the patient and facilitating further penetration of organized players in the market.

Key Segments Covered

India Diagnostic Laboratories Market

  • Revenue Segmentation by Government and Private Labs

Government Labs

Private Labs

India Private Diagnostic Laboratories Market

  • Revenue Segmentation by Pathology and Radiology

Pathology Sector

Radiology Sector

  • Revenue Segmentation by Pathology

Clinical Biology

Hematology

Surgical Pathology

Histopathology

Clinical Microbiology

Molecular Biology

Others

  • Revenue Segmentation by Radiology

X-rays

Sonography

MRI

CT Scans

Mammography

PET

Others

  • Revenue Segmentation by Business Model

Standalone

Diagnostic Chains

Hospital Based Labs

  • Revenue Segmentation by Diagnostic Chains 

Regional Chains

Large PAN-India Chains

  • Revenue Segmentation by Tier I, II and III Cities 

Tier I cities

Tier II cities

Tier III cities

  • Revenue Segmentation by Organized and Unorganized Players 
  • Revenue Segmentation by Type of Customers

Referrals

Walk Ins

Corporate Client

  • Revenue Segmentation by Payment Method

Out of Pocket Expenditure

Corporate Spending

Insurance

Key Target Audience

Government Diagnostic Labs

Private Diagnostic Labs

Research Labs

Medical Insurance Companies

Medical Device Manufacturers

Industry Associations

Government Bodies

Investors/VC’s

Time Period Captured in the Report:

Historical Period: FY’2015-FY’2020

Forecast Period: FY’2020-FY’2025

Companies Mentioned:

Dr. Lal Pathlabs

SRL Diagnostics

Metropolis Healthcare

Thyrocare Technologies

Medall Healthcare Pvt Ltd

Suraksha Diagnostics Pvt Ltd

Suburban Diagnostics

Neuberg Diagnostics

Key Topics Covered in the Report

Spread of Communicable and Non-Communicable Diseases in India

Market Sizing Analysis of Diagnostic Labs in India

Ecosystem of Diagnostic Labs in India

Operating Models in India Diagnostic Labs

Pricing Analysis in India Diagnostic Labs Market

Value Chain Analysis of India Diagnostic Labs Market

Decision Making Parameters for a Diagnostic Lab

Issues and Challenges in the Industry

Government Regulations in the Industry

Segmentation by Radiology and Pathology

Segmentation by Type of Business Model (Standalone, Hospital Based Labs and Diagnostic Chains)

Upcoming Trends and Technologies in the Market

Competition Scenario and Market Share

Investment Model for a Franchise Lab in India

Success Stories of Diagnostic Labs in India 

READ MORE

Scope

1.            Executive Summary

2.            Research Methodology

2.1.        Market Definitions

2.2.        Abbreviations

2.3.        Market Size and Modeling

3.            Communicable and Non Communicable Diseases in India

4.            India Diagnostic Laboratory Market Ecosystem

5.            Operating Models Followed  in India Diagnostic Laboratories Market

5.1.        Hub-and-Spoke Model

5.2.        Customer Reach Out Model for Diagnostic Chains

6.            India Diagnostic Laboratories Market Pricing Analysis

6.1.        Government Initiative to Reduce Out of Pocket Expenditure

7.            India Diagnostic Laboratories Market Value Chain, FY’ 2020

8.            India Diagnostic Laboratories Market Size, FY’2015-FY’2020

8.1.        By Government and Privately Owned Diagnostic Laboratories, FY’2020

9.            India Private Diagnostic Laboratories Market Segmentation FY’2020

9.1.        By Radiology and Pathology Laboratories, FY’2020

9.2.        By Business Model (Standalone Centers/Polyclinics, Hospital Based Labs and Diagnostic Chains), FY’2020

9.3.        By Diagnostic Chains (Regional Chains and Large PAN-India Labs) FY’2020

9.4.        By Tier I, Tier II, and Tier III Cities, FY’2020

9.5.        By Organized and Unorganized Players, FY’2020

9.6.        By Type of Customers (Referrals, Walk Ins and Corporate Clients), FY’2020

9.7.        By Cause for Testing (Sick Care and Wellness), FY’2020

9.8.        By Payment Method (Out of Pocket Expenditure, Corporate Spending and Insurance), FY’20

10.         Snapshot on India Private Pathology Tests Market

10.1.     India Private Pathology Tests Market Size By Revenue, FY’2020

10.2.     India Pathology Tests Market Segmentation By Type of Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology and Molecular Biology), FY’2020

11.         Snapshot on India Private Radiology Tests Market

11.1.     India Private Radiology Tests Market Size By Revenue, FY’2020

11.2.     India Private Radiology Tests Market Segmentation By Type of Tests (X-Rays, Sonography, MRI, CT Scans, Mammography and PET), FY’2020

12.         Decision Making Process of Customers for Choosing Diagnostic Laboratories

13.         Trends and Developments in India Private Diagnostic Laboratories Market

13.1.     Advancements in Technology

13.2.     Collaboration of Diagnostic Healthcare Service Providers with Corporate Entities

13.3.     Increasing Penetration of Medical Insurance

13.4.     Regulating Telemedicine Industry Helping Diagnosis

13.5.     Shift Towards Molecular Pathology and Genetics Testing

14.         Growth Drivers for the Diagnostic Laboratory Industry

14.1.     Growth of Population and Income Levels in India

14.2.     Rise of Communicable and Non-Communicable Diseases

14.3.     Usage of Laboratory Diagnostics as a tool in Clinical Practice

14.4.     India Emerging as a Medical Tourism Destination

15.         Issues and Challenges in the Indian Diagnostics Industry

15.1.     Lack of Regulations

15.2.     High Equipment Cost

15.3.     Lack of Knowledge Among the Consumers

15.4.     Growing Operating Expenses

16.         Industry Speaks

16.1.     Interview with Mr. Arindam Haldar, Chief Executive Officer at SRL Limited

16.2.     Interview with Dr. Kunal Sharma, SRL Reference laboratory and Consultant Oncopathologist- Fortis Hospitals, Bangalore

16.3.     Interview with Mr. Indranil Roy Choudhury, Chief Operating Officer at Diagno Labs Pvt Ltd

17.         Investment Model for Setting Up a Diagnostic Laboratory

18.         Regulatory Environment for India Diagnostic Laboratories Market

18.1.     Licenses and Other Regulations

19.         India Diagnostic Laboratory Market SWOT Analysis

20.         India Diagnostic Laboratories Market Company Profiles (Company Overview, USP, Services Portfolio, Number of Locations, Number of Centers, Business Strategies, Number of Employees, Mergers and Acquisitions and Company Financials)

20.1.     SRL Diagnostics, FY’2020

20.2.     Dr. Lal Pathlabs, FY’2020

20.3.     Metropolis Healthcare Limited, FY’2020

20.4.     Thyrocare Technologies Limited , FY’2020

20.5.     Suraksha Diagnostics Pvt Ltd, FY’2020

20.6.     Medall Healthcare Pvt. Ltd., FY’2020

20.7.     Suburban Diagnostics, FY’2020

20.8.     Neuberg Diagnostics, FY’2020

21.         India Diagnostic Laboratories Market Competitive Landscape

21.1.     India Diagnostic Laboratories Market Cross Comparison for Major Players (Dr. Lal Pathlab, SRL Diagnostics, Metropolis Healthcare and Thyrocare Technologies Ltd ) Based on Accreditations, International Presence, Revenue in INR Cr (FY’2019) and Number of Lbs, FY’2020

21.2.     India Diagnostic Laboratory Market Strengths and Weakness of Major Players (Dr. Lal Pathlabs, SRL Diagnostics, Metropolis Healthcare and Thyrocare Techbologies Limited), FY’20

21.3.     Market Share of Major Players in India Private Organised  Diagnostic Laboratories Market (Dr. Lal Pathlabs, SRL Diagnostics, Thyrocare Technologies, Metropolis Healthcare, Medall Healthcare Pvt Ltd., Suraksha Diagnostics Pvt Ltd, Suburban Diagnostics and Others), FY’2019

22.         India Diagnostic Laboratories Market Future Outlook and Projections, FY’2020 – FY’2025

22.1.     Revenue by Government and Private Diagnostic Laboratories, FY’2020 and FY’2025

22.2.     Impact of COVID-19 on the Indian Diagnostic Laboratories Market

23.         India Private Diagnostic Laboratories Market Future Outlook, FY’2020 and FY’2025

23.1.     Revenue By Radiology and Pathology Tests, Fy’2020 and FY2025

23.1.     Revenue By Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology Molecular Biology and Others), Fy’2020 and FY2025

23.2.     Revenue By Radiology Tests (X-Rays, Sonography, MRI, CT Scans, Mammography, PET and Others ), Fy’2020 and FY2025

23.3.     Revenue By Tier I, Tier II and Tier III Cities, FY’2020 and FY’2025

23.4.     Revenue By Organized and Unorganized Players, FY’2020 and FY’2025

23.5.     Revenue By Business Model (Standalone Centers/Polyclinics, Hospital Based Labs and Diagnostic Chains), FY’2020 and FY’2025

23.1.     Revenue by Diagnostic Chains (Regional Labs and Large PAN-India Labs), FY’2020 and FY’2025

23.2.     Revenue by Type of Customers (Referrals, Walk Ins and Corporate Clients) FY’2020 and FY’2025

23.3.     Revenue By Cause for Testing (Wellness and Sick-Care) FY’2020 and FY’2025

Revenue by Payment Method ( Out of Pocket Expenditure, Insurance and Corporate Spending ) FY’2020 and FY’2025

24.         India Diagnostic Laboratories Market Success Stories

24.1.     Krsnaa Diagnostics – Sustainable PPPs

24.2.     Healthians- Asset Light Model

25.         Analyst Recommendations

Disclaimer

Contact Us


List Of Figure

Figure 1‑1: India Diagnostic Laboratories Market Flowchart on the basis of Revenue in INR Cr, FY’2020

Figure 1‑2: India Diagnostic Laboratories Market Flowchart in terms of Revenue (INR Cr), FY’25

Figure 3‑1: Mortality reported by Major Communicable Diseases in India in 2018

Figure 5‑1: India Diagnostic Laboratories Market Hub-and-Spoke Model Followed by Diagnostic Chains

Figure 5‑2: India Diagnostics Laboratory Market Hub and Spoke Model used in a Regional Lab

Figure 5‑3: India Diagnostics Laboratory Market Logistics Functioning in Customer Reach Out Model

Figure 8‑1: India Diagnostic Laboratories Market on the basis of Revenue in INR Crore and Growth Rate in Percentage (%), FY’2015 - FY’2020

Figure 8‑2: India Diagnostic Laboratories Market by Government and Privately owned Laboratories on the basis of Revenue in Percentage, FY’2020

Figure 9‑1: India Private Diagnostic Laboratories Market Segmentation by Pathology Labs and Radiology Labs on the basis of Revenue in Percentage (%), FY’2020

Figure 9‑2: India Private Diagnostic Laboratories Market Segmentation by Standalone Centers/Polyclinics, Hospital Based Labs and Diagnostic Chains on the basis of Revenue in Percentage, FY’2020

Figure 9‑3: India Private Diagnostic Laboratories Market Segmentation by Diagnostic Chains (Regional Labs and PAN-India Level Labs) on the basis of Revenue in Percentage, FY’2020

Figure 9‑4: India Private Diagnostic Laboratories Market Segmentation by Tier Cities (Tier I, Tier II, Tier III) on the basis of Revenue in Percentage, FY’2020

9‑5: India Private Diagnostic Laboratories Market Segmentation by Organised and Unorganized Players on the Basis of Revenue in Percentage (%), FY’2020

Figure 9‑6: India Private Diagnostic Laboratories Market Segmentation by Type of Customers (Referrals, Walk Ins and Corporate Clients) on the basis of Revenue in Percentage (%), FY’2020

Figure 9‑7: India Private Diagnostic Laboratories Market Segmentation by Cause for Testing (Sick Care and Wellness) on the basis of Revenue in Percentage (%), FY’2020

Figure 9‑8: India Private Diagnostic Laboratories Market Segmentation by Payment Method (Out of Pocket Expenditure, Corporate Spending and Insurance) on the basis of Revenue in Percentage (%), FY’2020

Figure 10‑1: India Private Pathology Tests Market Segmentation by Type of Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology, Molecular Biology and others) on the Basis of Revenue in Percentage, FY’2020

Figure 11‑1: India Private Radiology Tests Market Segmentation by Type of Tests (X-Ray, Sonography, MRI, CT Scan, Mammography, PET/SPECT) on the basis of Revenue in Percentage, FY’2020

Figure 13‑1: Medical Insurance Market in India on the Basis of Premium in INR Crore, FY’2015 - FY’2019

Figure 14‑1: Population Growth in India in Crore, 2013-2020 (P)

Figure 20‑1: Dr. Lal Pathlabs Financial Performance including Revenue from Operations in India in INR Cr, FY’2015-FY-2019

Figure 20‑2: Dr. Lal Pathlabs Geographical Revenue Breakup in terms of Percentage (%), FY’2018 and FY’2019

Figure 20‑3: Dr. Lal Pathlabs Number of Clinical Labs in India, FY’2015-FY’2019

Figure 20‑4: Thyrocare Technologies Limited Geographical Revenue Breakup in terms of Percentage (%), FY’2018 and FY’2019

Figure 20‑5: Operational Performance of Thyrocare Technologies Limited on the basis of Samples Processed (‘000), FY’2015-FY’2019

Figure 21‑1: India Private Organised Diagnostic Laboratories Market Competition including Market Share for Major Companies (Dr. Lal Pathlabs, SRL Diagnostics, Thyrocare Technologies, Metropolis Healthcare, Medall Healthcare Pvt Ltd., Suraksha Diagnostics Pvt Ltd, Suburban Diagnostics and others) in Revenue Percentage (%), FY’2019

Figure 22‑1: India Diagnostic Laboratories Market Future Outlook on the basis of Revenue in INR Crore and Growth Rate in Percentage (%), FY’2020-FY’2025

Figure 22‑2: India Diagnostic Laboratories Market Segmentation Future Outlook by Government and Private Laboratories on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑1: India Private Diagnostic Laboratories Market Segmentation Future Outlook  by Pathology and Radiology Tests on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑2: India Private Diagnostic Laboratories Market Segmentation Future Outlook  by Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology, Molecular Biology and others) on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑3: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Radiology Tests (X-Rays, Sonography, MRI, CT Scans, Mammography, PET and others) on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑4: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Tier I, Tier II and Tier III Cities on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑5: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Organized and Unorganized Players on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑6: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Model Type (Standalone centers, Hospital Based Labs and Diagnostic Chains) on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑7: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Diagnostic Chains (Regional Labs and Large PAN-India Labs) on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑8: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Type of Customers (Referrals, Walk Ins and Corporate Clients) on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑9: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Cause of Testing (Wellness and Sick Care) on the Basis of Revenue in Percentage, FY’2020 and FY’2025

Figure 23‑10: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Payment Method (Out of Pocket Expenditure, Insurance and Corporate Spending) on the Basis of Revenue in Percentage, FY’2020 and FY’2025


List Of Table

Table 2‑1: Consolidated Research Approach for India Diagnostic Labs Market

Table 2‑2: Sample Size Including Major Players in India Diagnostic Labs Market and Industry Experts

Table 2‑3: Sample Size Inclusion Table Including Respondent Category and Percentage of Sample Size

Table 2‑4: Tentative Set of Questions Asked by Mode of Entities and Desired Outcome

Table 2‑5: Correlation Matrix of India Diagnostic Labs Market

Table 2‑6: Regression Coefficients Outputs of India Diagnostic Labs Market

Table 3‑1: Demographic Factors including Birth Rate, Death Rate and Natural Growth Rate for India on the basis of Urban and Rural Regions in Percentage (%), 2012-2017

Table 3‑2: Deaths caused by Acute Respiratory Infections, Acute Diarrhea and Pneumonia in India State Wise, 2017 and 2018(P)

Table 3‑3: Number of People Diagnosed with Non Communicable Diseases (Diabeters, Hypertension, HTN &DM, Cardiovascular Diseases (CVDs), Stroke and Common Cancer) in 2018

Table 4‑1: India Diagnostic Laboratory Market Ecosystem , FY’2020

Table 5‑1: India Diagnostics Laboratory Market on the basis of Different Type of Business Models (Hospital based labs, Diagnostic Chains and Standalone Centers)

Table 5‑2: India Diagnostics Laboratory Market Components of Hub-and-Spoke Model

Table 6‑1: India Diagnostic Laboratory Market Price/Average Cost of Diagnostic Tests across Cities, 2017

Table 7‑1: India Diagnostic Laboratories Market Value Chain, FY’2020

Table 7‑2: Role of Entities in the India Diagnostic Laboratory Market Value Chain

Table 8‑1: India Diagnostic Laboratory Market Cross Comparison of Privately Owned Laboratories and Government Owned Laboratories on the basis of Convenient Sample Collection, Customer Reach, Time taken for Results and Examples, FY’20

Table 8‑2: India Diagnostic Laboratory Market Comparative Prices for Key Diagnostic Tests in Government Owned and Privately Owned Laboratories, 2019

Table 8‑3: India Diagnostic Laboratories Market by Government and Privately owned Laboratories on the basis of Revenue in INR Crore, FY’2020

Table 9‑1: Cross Comparison of Pathology and Radiology Laboratories on the basis of Growth Factors, Economies of Scale, Barriers to Entry and Specific Accreditations/Approvals Required

Table 9‑2: India Private Diagnostic Laboratories Market Segmentation by Pathology Tests and Radiology Tests on the basis of Revenue in terms of INR Crore, FY’2020

Table 9‑3: India Diagnostic Laboratory Market Cross Comparison of Standalone/Polyclincs, Hospital Based Labs and Diagnostics Chains on the basis of Type of Players, Availability of Tests, Investments and Examples, FY’ 2020

Table 9‑4: India Private Diagnostic Laboratories Market Segmentation by Model Type (Standalone Centers/Polyclinics, Hospital Based Labs and Diagnostic Chains) on the Basis of Revenue in INR Crore, FY’2020

9‑5: India Diagnostic Laboratory Market Cross Comparison of Diagnostic Chains (Regional Chains and Large PAN-India Labs on the basis of Number of Players, Customer Base and Examples), FY’20

Table 9‑6: India Private Diagnostic Laboratories Market Segmentation by Diagnostic Chains (Regional Labs and PAN-India Level Labs) on the Basis of Revenue in INR Crore, FY’2020

Table 9‑7: India Private Diagnostics Laboratory Market Cross Comparison of Tier I, Tier II and Tier III cities on the basis of Composition of Establishments, Pricing and Growth Factors, FY’2020

Table 9‑8: India Private Diagnostic Laboratories Market Segmentation by Tier Cities (Tier I, Tier II, Tier III) on the basis of Revenue in INR Crore, FY’2020

Table 9‑9: India Private Diagnostics Laboratory Market Cross Comparison of Organised Players and Unorganized Players on the basis of Presence, Operating Model, Promotional Activities and Regulations Followed, FY’2020

Table 9‑10: Major Organized Players in India Private Laboratories Market and their Presence across India, 2019

Table 9‑11: India Private Diagnostic Laboratories Market Segmentation by Organised and Unorganized Players on the basis of Revenue in INR Crore, FY’2020

Table 9‑12: India Private Diagnostic Laboratory Market Cross Comparison of Type of Customers (Referrals, Walk Ins, Corporate Clients) on the basis of Type of Model Preferred, Type of Testing Conducted and Mode of Payment, FY’2020

Table 9‑13: India Private Diagnostic Laboratories Market Segmentation by Type of Customers (Referrals, Walk-Ins and Corporate Clients on the basis of Revenue in INR Crore, FY’2020

Table 9‑14: India Private Diagnostic Laboratories Market Segmentation by Cause for Testing (Sick Care and Wellness) on the basis of Revenue in INR Crore, FY’2020

Table 9‑15: India Private Diagnostic Laboratories Market Segmentation by Payment Method (Out of Pocket Expenditure, Corporate Spending and Insurance) on the basis of Revenue in INR Crore, FY’2020

Table 10‑1: India Private Pathology Tests Market Cross Comparison of Type of Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology and Molecular Biology) on the basis of Purpose, Common Tests Performed in India and Growth Factors,  FY’2020

Table 10‑2: Private Pathology Tests Market Segmentation by Type of Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology, Molecular Biology and others) on the Basis of Revenue in INR Crore, FY’2020

Table 11‑1: India Private Radiology Tests (X-rays, Sonography, MRI, CT Scans, Mammography and PET) Cross Comparison on the basis of Purpose, Average Price and Growth Factor, FY’2020

Table 11‑2: India Private Radiology Tests Market Segmentation by Type of Tests (X-Ray, Sonography, MRI, CT Scan, Mammography, PET/SPECT) on the basis of Revenue in INR Crore, FY’2020

Table 12‑1: India Diagnostic Laboratory Market Rationale for Decision Making Process of Customers while Choosing a Diagnostic Laboratory, FY’2020

Table 17‑1: Parameters for Setting up a Franchise Laboratory in India

Table 17‑2: Equipment Expenditure for Pathology Laboratories in India in INR

Table 17‑3: Equipment Expenditure for Radiology Laboratories in India in INR

Table 17‑4: Total Fixed Cost for Setting up a Franchise Diagnostic Laboratory in India in INR

Table 17‑5: Annual Salaries of Diagnostic Laboratories Professionals on the basis of Salaries per Profession in terms of INR in India

Table 17‑6: Annual Human Resource Expenses in terms of INR in India

Table 17‑7: Annual Expenses of Franchised Diagnostic Laboratory in India in INR

Table 17‑8: Means of Finance for Setting up a Franchised Diagnostic laboratory in India in INR

Table 17‑9: Annual Operating Expenses of a Franchised Diagnostic laboratory in India in INR

Table 17‑10: Financial Indicators Related to Franchised Diagnostic laboratory in India in INR

Table 19‑1: India Diagnostic Laboratory Market SWOT Analysis

Table 20‑1: Company Profile of SRL Diagnostics including Company Overview, USP, Services Portfolio , Number of Locations, Number of Centers, Service Portfolio, Business Strategies, Awards, Joint Ventures, Mergers and Acquisitions and Recent Developments, FY’2020

Table 20‑2: SRL Diagnostics Financial Parameters including Revenue from Operations, Other Incomes, Total Income, Profit before Tax and Profit for the Year in INR CR, FY’2016-FY’2019

Table 20‑3: Company Profile of Dr. Lal Pathlabs including Company Overview, USP, Number of Locations, Number of Tests, Service Portfolio, Business Strategies, Recent Developments, Mergers and Acquisitions and Number of Employees, FY’2020

Table 20‑4: Dr. Lal Pathlabs Financial Parameters including Revenue from Operations, Other Income, Total Income, Profit before Tax, Profit After Tax and EBITA Margin (%), in INR Cr, FY’2015-FY’2019

Table 20‑5: Company Profile of Metropolis Healthcare including Company Overview, US, Number of Centers, Service Portfolio, Business Strategies, Number of Employees, Awards, Recent Developments and Mergers and Acquisitions, FY’2020

Table 20‑6: Metropolis Healthcare Limited Number of Clinics State Wise in India, FY’ 2019

Table 20‑7: Metropolis Healthcare Limited Number of Tests (Mn) and Revenue per Test (INR), FY2016-FY’2019

Table 20‑8: Metropolis Healthcare Limited Financial Parameters including Revenue from Operations, Other Revenue, Total Revenue, Profit before Tax and EBITDA (%) in INR Crore, FY’2018 and FY’2019

Table 20‑9: Metropolis Healthcare Limited Financial Parameters including Revenue Breakup by Geography (India and Overseas) in INR Crore, FY’2018 and FY’2019

Table 20‑10: Company Profile of Thyrocare Technologies Limited including Company Overview, USP, Number of Locations, Number of Tests, Services Portfolio, Number of Centers, Business Strategies, Number of Employees and Recent Developments, FY’2020

Table 20‑11: Thyrocare Technologies Finanacial Parameters including Income from Operations, EBITDA, Profit before tax and Profit for the Year in INR Crore, FY’2015-FY’2019

Table 20‑12: Company Profile of Suraksha Diagnostics Pvt. Ltd. including Company Overview, USP , Service Portfolio, Number of Diagnostic Centers, Location, Recent Developments and Awards, FY’2020

Table 20‑13: Suraksha Diagnostics Pvt Ltd. Financial Parameters including Revenue form Operations, Other Income, Total Revenue and Total Profit/Loss for the year in INR Cr, FY’2014 – FY’2019

Table 20‑14: Company Profile for Medall Healthcare Pvt. Ltd. including Company Overview, Number of Diagnostic Centers, Number of Tests Conducted, Location, Number of Employees, Service Portfolio, Recent Developments and Awards, FY’2020

Table 20‑15: Medall Healthcare Financial Parameters including Total Income and Profit/Loss for the Year in INR Cr, FY’2014 – FY’2018

Table 20‑16: Company Profile of Suburban Diagnostics Pvt. Ltd. including Company Overview, USP , Service Portfolio, Number of Diagnostic Centers, Location, Recent Developments and Awards, FY’2019

Table 20‑17: Suburban Diagnostics Pvt Ltd. Financial Parameters including Revenue from Operations, Other Income, Total Revenue and Total Profit/Loss for the year in INR Cr, FY’2014 – FY’2019

Table 20‑18: Company Profile of Neuberg Diagnostics  including Company Overview, USP , Service Portfolio, Number of Diagnostic Centers, Location, Recent Developments. Accreditations, Awards, New Technologies and Investments, FY’2020

Table 21‑1: India Diagnostic Market Cross Comparison of Major Players including Dr. Lal Pathlab, SRL Diagnostics, Metropolis Healthcare and Thyrocare Technologies Ltd based on Accreditations, International Presence, Revenue in INR Cr (FY’2019) and Number of Labs, FY’2020

Table 21‑2: India Diagnostic Laboratory Market Strengths and Weakness of Major Players including Dr. Lal Pathlabs, SRL Diagnostics, Metropolis Healthcare and Thyrocare Techbologies Limited, FY’20

Table 21‑3: India Diagnostic Laboratory Market Price Comparison for Different Pathology Tests (Lipid Profile, Vitamin B12 and Vitamin D) in Dr. Lal Pathlabs, SRL Diagnostics, Metropolis Healthcare and Thyrocare Technologies Limited, in Mumbai FY’2019

Table 21‑4: India Private Organised Diagnostic Laboratories Market Competition including Market Share for Major Companies (Dr. Lal Pathlabs, SRL Diagnostics, Thyrocare Technologies, Metropolis Healthcare, Medall Healthcare Pvt Ltd., Suraksha Diagnostics Pvt Ltd, Suburban Diagnostics and others)  in Revenue (INR Cr), FY’2019

Table 22‑1: India Diagnostic Laboratories Market Segmentation Future Outlook by Government and Private Laboratories Tests on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 22‑2: NABL Accredited Private Labs for COVID-19 Testing Statewise, March 2020

Table 23‑1: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Pathology and Radiology Tests on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑2: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology, Molecular Biology and others ) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑3: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Radiology Tests (X-Rays, Sonography, MRI, CT Scans, Mammography PET and others) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑4: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Tier I, Tier II and Tier III Cities on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑5: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Organised and Unorganized Players on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑6: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Model Type (Standalone centers, Hospital Based Labs and Diagnostic Chains) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑7: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Diagnostic Chains (Regional Labs and Large PAN-India Labs) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑8: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Type of Customers (Referrals, Walk Ins and Corporate Clients) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑9: India Private Diagnostic Laboratories Market Segmentation Future Outlook by by Cause of Testing (Wellness and Sick Care) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 23‑10: India Private Diagnostic Laboratories Market Segmentation Future Outlook by Payment Method (Out of Pocket Expenditure, Insurance and Corporate Spending) on the Basis of Revenue in INR Crore, FY’2020 and FY’2025

Table 24‑1: India Diagnostic Laboratories Market Cross Comparison of Prices at KRsnaa Diagnostics, Apollo, SRL Diagnostics, Vijaya Diagnostics and Medall, FY’19

Table 25‑1: Analyst Recommendations for India Private Diagnostic Laboratories Market

License Type Excel Only Single User Single User + Excel Hard Copy Corporate User License
User Sharing Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Access to Printed Report; No Soft Copy Multiple Users within the Company/ Enterprise
Print Option
Copy Option :Yes :No
Citation Yes (Not Publically; but to Private Parties within the company/ affiliate)
Deliverable Format :via Email :via Email ; :via Email Printed Publication/ Book by Post ; :via Email
Customization 20%
Analyst Time (Post Purchase Queries on Call/ Email)
Disclaimer : In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

In-depth Analysis of the COVID-19 impact on India Diagnostic Laboratories Market

Respecting industry experts that are helping companies to survive and to sustain in this economic pandemic. We are working day and night to aid companies in taking rapid-decisions by finding

 

  • COVID-19 Impact on diagnostic services market, growth/decline in the industry player’s revenue, new service offerings, government support and regulations  etc.

  • How major diagnostic laboratories services players are making rapid shifts in their strategies to survive the affects of the pandemic

  • Major short-term and long term shifts in the industry performance

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Key Segments Covered

India Diagnostic Laboratories Market

  • Revenue Segmentation by Government and Private Labs

Government Labs

Private Labs

India Private Diagnostic Laboratories Market

  • Revenue Segmentation by Pathology and Radiology

Pathology Sector

Radiology Sector

  • Revenue Segmentation by Pathology

Clinical Biology

Hematology

Surgical Pathology

Histopathology

Clinical Microbiology

Molecular Biology

Others

  • Revenue Segmentation by Radiology

X-rays

Sonography

MRI

CT Scans

Mammography

PET

Others

  • Revenue Segmentation by Business Model

Standalone

Diagnostic Chains

Hospital Based Labs

  • Revenue Segmentation by Diagnostic Chains 

Regional Chains

Large PAN-India Chains

  • Revenue Segmentation by Tier I, II and III Cities 

Tier I cities

Tier II cities

Tier III cities

  • Revenue Segmentation by Organized and Unorganized Players 
  • Revenue Segmentation by Type of Customers

Referrals

Walk Ins

Corporate Client

  • Revenue Segmentation by Payment Method

Out of Pocket Expenditure

Corporate Spending

Insurance

Key Target Audience

Government Diagnostic Labs

Private Diagnostic Labs

Research Labs

Medical Insurance Companies

Medical Device Manufacturers

Industry Associations

Government Bodies

Investors/VC’s

Time Period Captured in the Report:

Historical Period: FY’2015-FY’2020

Forecast Period: FY’2020-FY’2025


Companies

Companies Mentioned:

Dr. Lal Pathlabs

SRL Diagnostics

Metropolis Healthcare

Thyrocare Technologies

Medall Healthcare Pvt Ltd

Suraksha Diagnostics Pvt Ltd

Suburban Diagnostics

Neuberg Diagnostics